CD14 and non-small cell lung carcinoma: Likewise, non-small cell lung cancer patients treated with RT (2.75 Gy in 24 fractions) preceding by low-dose cisplatin were intensively infiltrated with CD14+HLA-DRlow and CD14+CD33+HLA-DRlow MDSCs (70).